DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Zinner N, Susset J, Gittelman M. et al.
Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB.
Int J Clin Pract 2006;
60: 119-126
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.